FundedIQ
Biotechnology

Bondwell Technologies: Funding, Investors & Team (Sep 2026)

Bondwell Technologies is a company established in 2017 by scientists from Texas A&M University and is located in College Station, TX. It specializes in the commercialization of an innovative platform technology based on biomaterials. This technology harnesses the inherent capabilities of proteins, crucial molecules for various natural processes, to make advancements in the fields of energy, environment, and medicine.

www.bondwelltech.com LinkedIn College Station, United States 11-50 employees
Total raised
$450k
Rounds
1
Latest
Seed
Nov 2023

Bondwell Technologies has raised $450k across 1 funding round on record, the most recent a Seed of $450k announced in Nov 2023.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Bondwell Technologies Company Profile and Key Stats

Total funding raised
$450k
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$450k in Nov 2023
Employees
11-50
reported band
Headquarters
College Station, United States

Latest funding round on record: Nov 2023.

Bondwell Technologies Funding Rounds

Date
Round
Amount
Seed
$450k

Bondwell Technologies Founders and Leadership Team

Name
Role
Contact
David Howell
CEO

No contact details are on record for this team yet.

Bondwell Technologies Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,183
$8.0M
29,878
$7.5M
16,664
$3.1M

Bondwell Technologies' latest round of $450k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Bondwell Technologies in Biotechnology and College Station

Companies Similar to Bondwell Technologies

SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…

Undisclosed round $960k

DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…

Series B $4.0M

Solstice Oncology is a clinical stage immuno-oncology company

Series A $225M

Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…

Series F $275M

BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…

Series A $116M

Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…

Series B $65.5M

Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…

Seed $7.0M

ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…

Series C $10.0M

EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…

Series A $35.0M

Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…

Convertible Note $3.5M

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Bondwell Technologies Funding FAQs

What does Bondwell Technologies do?

Bondwell Technologies is a company established in 2017 by scientists from Texas A&M University and is located in College Station, TX. It specializes in the commercialization of an innovative platform technology based on biomaterials. This technology harnesses the inherent capabilities of proteins, crucial molecules for various natural processes, to make advancements in the fields of energy, environment, and medicine.

How much funding has Bondwell Technologies raised?

Bondwell Technologies has raised $450k across 1 round on record. The most recent is a Seed of $450k announced in Nov 2023.

When did Bondwell Technologies last raise funding?

Bondwell Technologies' most recent funding round on record is a Seed of $450k, announced in Nov 2023.

Who is the CEO of Bondwell Technologies?

David Howell is listed as CEO at Bondwell Technologies.

Where is Bondwell Technologies headquartered?

Bondwell Technologies is based in College Station, Texas, United States.

How many employees does Bondwell Technologies have?

Bondwell Technologies is in the 11-50 employee band.

How does Bondwell Technologies' funding compare to other Biotechnology startups?

Bondwell Technologies' latest round of $450k is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.

About FundedIQ's Bondwell Technologies Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Bondwell Technologies is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.